3-19984917-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1
The ENST00000273047.9(RAB5A):c.*1094C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.205 in 154,100 control chromosomes in the GnomAD database, including 3,922 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.21 ( 3905 hom., cov: 32)
Exomes 𝑓: 0.13 ( 17 hom. )
Consequence
RAB5A
ENST00000273047.9 3_prime_UTR
ENST00000273047.9 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.822
Genes affected
RAB5A (HGNC:9783): (RAB5A, member RAS oncogene family) Enables GDP binding activity; GTP binding activity; and GTPase activity. Involved in several processes, including amyloid-beta clearance by transcytosis; early endosome to late endosome transport; and regulation of exocytosis. Located in several cellular components, including cytoplasmic side of early endosome membrane; nucleoplasm; and terminal bouton. [provided by Alliance of Genome Resources, Apr 2022]
PP2D1 (HGNC:28406): (protein phosphatase 2C like domain containing 1) Predicted to enable protein serine/threonine phosphatase activity. Predicted to be involved in protein dephosphorylation. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 3-19984917-C-G is Benign according to our data. Variant chr3-19984917-C-G is described in ClinVar as [Benign]. Clinvar id is 1178729.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.34 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAB5A | NM_004162.5 | c.*1094C>G | 3_prime_UTR_variant | 6/6 | ENST00000273047.9 | NP_004153.2 | ||
RAB5A | NM_001292048.2 | c.*1094C>G | 3_prime_UTR_variant | 6/6 | NP_001278977.1 | |||
RAB5A | XM_047448648.1 | c.*1094C>G | 3_prime_UTR_variant | 6/6 | XP_047304604.1 | |||
PP2D1 | NR_027694.2 | n.1283-621G>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAB5A | ENST00000273047.9 | c.*1094C>G | 3_prime_UTR_variant | 6/6 | 1 | NM_004162.5 | ENSP00000273047.4 | |||
PP2D1 | ENST00000333083.11 | n.1091-621G>C | intron_variant | 1 | ENSP00000331295.7 |
Frequencies
GnomAD3 genomes AF: 0.206 AC: 31361AN: 151906Hom.: 3901 Cov.: 32
GnomAD3 genomes
AF:
AC:
31361
AN:
151906
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.134 AC: 278AN: 2078Hom.: 17 Cov.: 0 AF XY: 0.126 AC XY: 151AN XY: 1198
GnomAD4 exome
AF:
AC:
278
AN:
2078
Hom.:
Cov.:
0
AF XY:
AC XY:
151
AN XY:
1198
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.206 AC: 31376AN: 152022Hom.: 3905 Cov.: 32 AF XY: 0.205 AC XY: 15197AN XY: 74306
GnomAD4 genome
AF:
AC:
31376
AN:
152022
Hom.:
Cov.:
32
AF XY:
AC XY:
15197
AN XY:
74306
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
644
AN:
3472
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 25, 2021 | This variant is associated with the following publications: (PMID: 28171541) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at